Aligos Therapeutics ALG-055009 Phase 2a HERALD Conference Call

Sep 19, 2024 8:30 AM EDT

Supporting Materials

Print Page

Email Alerts

RSS

Investor FAQs

US OFFICE 1 Corporate Dr., 2nd Floor South San Francisco, CA 94080

EU OFFICE Gaston Geenslaan 1 / (Building 3) 3001 Leuven, Belgium

CHINA OFFICE Unit 3212, Building A, No. 100, Zunyi Road, Changning District, Shanghai, People’s Republic of China, 200051

© Aligos Therapeutics 2024